NASDAQ:TECH
Bio-Techne Corp Stock News
$83.81
+0.97 (+1.16%)
At Close: May 17, 2024
Zacks: Analysts Anticipate Bio-Techne Co. (NASDAQ:TECH) to Announce $1.82 Earnings Per Share
04:30pm, Friday, 26'th Nov 2021 Dakota Financial News
Equities research analysts expect Bio-Techne Co. (NASDAQ:TECH) to post $1.82 earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Bio-Technes earnings. The highest EPS estimate is $1.87 and the lowest is $1.78. Bio-Techne reported earnings of $1.62 per share in the same quarter last year, which []
Louisiana State Employees Retirement System Trims Stake in Bio-Techne Co. (NASDAQ:TECH)
12:46pm, Friday, 26'th Nov 2021 Transcript Daily
Louisiana State Employees Retirement System trimmed its stake in Bio-Techne Co. (NASDAQ:TECH) by 76.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 2,400 shares of the biotechnology companys stock after selling 7,700 shares during the period. Louisiana State Employees Retirement Systems holdings in Bio-Techne were worth $1,163,000 as of its most recent filing with []
Contrasting Outlook Therapeutics (NASDAQ:OTLK) and Bio-Techne (NASDAQ:TECH)
08:32am, Friday, 26'th Nov 2021 Dakota Financial News
Outlook Therapeutics (NASDAQ:OTLK) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Outlook Therapeutics and Bio-Technes revenue, earnings per share (EPS) and valuation. []
Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $476.00
07:16pm, Thursday, 25'th Nov 2021 Dakota Financial News
Bio-Techne Co. (NASDAQ:TECH) has been assigned a consensus rating of Buy from the nine analysts that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered []
Kim Kelderman Sells 500 Shares of Bio-Techne Co. (NASDAQ:TECH) Stock
11:12am, Thursday, 25'th Nov 2021 Dakota Financial News
Bio-Techne Co. (NASDAQ:TECH) insider Kim Kelderman sold 500 shares of the company’s stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $505.38, for a total value of $252,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed […]
Bio-Techne To Present At Upcoming Investor Conferences
07:00am, Monday, 22'nd Nov 2021
MINNEAPOLIS, Nov. 22, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at two upcoming investor conferences. Chuck Kummeth, President and Chief Executive
This fund company was an early believer in Tesla — it's now making these bets
08:44pm, Saturday, 20'th Nov 2021 MarketWatch
Baron funds took big stakes in Nvidia, Sea, Shopify and other companies in the third quarter.
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
11:20am, Wednesday, 17'th Nov 2021 Zacks Investment Research
Smart Beta ETF report for PBE
Tissue Microarray Market is Staring at a Promising Future Owing to High Demand for 2021 2027|Bio-Techne, Applied Microarrays, Z Biotech
09:50am, Tuesday, 16'th Nov 2021 OpenPR
Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently
3 Reasons Why Growth Investors Shouldn't Overlook Techne (TECH)
01:49pm, Monday, 08'th Nov 2021
Techne (TECH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
REGN vs. TECH: Which Stock Is the Better Value Option?
01:03pm, Monday, 08'th Nov 2021
REGN vs. TECH: Which Stock Is the Better Value Option?
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2022 Results - Earnings Call Transcript
02:52pm, Tuesday, 02'nd Nov 2021
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2022 Results - Earnings Call Transcript
Bio-Techne's Earnings: A Preview
11:03am, Monday, 01'st Nov 2021
Bio-Techne (NASDAQ:TECH) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.
Top-Performing Stocks From the High Quality Low CAPEX Model Portfolio
03:52pm, Friday, 29'th Oct 2021
In GuruFocus' High Quality Low CAPEX model portfolio, the companies with the biggest year-to-date returns are Fortinet Inc. ( FTNT , Financial), Nvidia Corp. ( NVDA , Financial), Old Dominion Freight
Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results
07:00am, Monday, 11'th Oct 2021
MINNEAPOLIS, Oct. 11, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021, at 8:00 a.m. CDT